Correction of hyperphosphataemia associated with chronic renal failure in patients undergoing dialysis.
Fresenius Kabi announced it has received FDA 510(k) clearance for the Aurora Xi Plasmapheresis System. The Aurora Xi Plasmapheresis System,...
Novavax, Inc. announced final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19 strain in a pivotal Phase III trial in the United Kingdom (U.K.) of NVX CoV2373, the company’s vaccine candidate.
NanoVibronix, Inc., medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, announced FDA 510(k) clearance of its PainShield MD PLUS, its dual-actuator ultrasound pain therapy device
Background: The original non-vitamin K antagonist oral anticoagulant (NOAC) trials in nonvalvular atrial fibrillation (AF) enrolled patients with native valve pathologies.
Medtronic has received U.S. FDA 510(k) clearance for the HawkOne Directional Atherectomy System in a new size for treating patients...
The FDA has cleared the Olympus TJF-Q180V duodenoscope with modifications to the device’s design and labeling intended to help reduce...
Novavax, Inc. has announced the completion of its rolling regulatory submission to the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for authorization of its COVID-19 vaccine candidate.